Mayumi Yamano

Title: Mayumi Yamano: Innovator in Pharmaceutical Research

Introduction

Mayumi Yamano is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of pharmaceutical research, particularly in the development of therapeutic agents for various medical conditions. With a total of 10 patents to her name, her work has had a substantial impact on the treatment of diseases.

Latest Patents

One of her latest patents focuses on a therapeutic agent for irritable bowel syndrome (IBS). This invention demonstrates that bombesin 2 (BB2) receptor antagonists, typified by RC-3095, are effective in treating both abdominal symptoms and bowel movement disorders associated with IBS. The invention provides a method for treating IBS using a bombesin 2 (BB2) receptor antagonist as an active ingredient. Another notable patent involves fused heteroaryl derivatives, which offer a pharmaceutical composition useful as a phosphatidylinositol 3 kinase (PI3K) inhibitor and an antitumor agent. This invention presents a novel bicyclic or tricyclic fused heteroaryl derivative or a salt thereof, showcasing excellent PI3K inhibiting activity and cancer cell growth inhibiting activity.

Career Highlights

Throughout her career, Mayumi Yamano has worked with various organizations, including Astellas Pharma GmbH. Her research has been pivotal in advancing pharmaceutical innovations and improving treatment options for patients.

Collaborations

Mayumi has collaborated with notable professionals in her field, including Masahiko Hayakawa and Hiroyuki Kaizawa. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Mayumi Yamano's contributions to pharmaceutical research and her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence the development of effective treatments for various medical conditions.